AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Stay informed with the latest in artificial intelligence
MIT Technology Review Explains: Let our writers untangle the complex, messy world of science and technology to help you understand what’s coming next. You can read more from the series here. Late last month, Anthropic released a report arguing that t
When Keelan Miskell began winding down his crypto startup this year, he didn’t think its data was worth much: the users were anonymous, the company just a few years old. But he’s since turned the firm’s digital archives into real money. He’s netted r
Ever since people first seriously contemplated giving machines an intelligence modeled on our own, there has never been any question that they would, like us, be able to say no. The sci-fi canon is full of stories of robotic disobedience. Most of the